Analysis of RET proto-oncogene abnormalities in patients with MEN 2A, MEN 2B, familial or sporadic medullary thyroid carcinoma.
Chiefari E, Russo D, Giuffrida D, Zampa GA, Meringolo D, Arturi F, Chiodini I, Bianchi D, Attard M, Trischitta V, Bruno R, Giannasio P, Pontecorvi A, Filetti S.
Chiefari E, et al. Among authors: trischitta v.
J Endocrinol Invest. 1998 Jun;21(6):358-64. doi: 10.1007/BF03350771.
J Endocrinol Invest. 1998.
PMID: 9699127